SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression

被引:20
|
作者
Jaiswal, AS [1 ]
Narayan, S [1 ]
机构
[1] Univ Florida, Coll Med, Dept Anat & Cell Biol, UF Shands Canc Ctr, Gainesville, FL 32610 USA
关键词
DNA alkylation; p53; phosphorylation; DNA-binding; p21 gene regulation;
D O I
10.1016/S0027-5107(01)00296-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
p53 is an important player in the cellular response to genotoxic stress whose functions are regulated by phosphorylation of a number of serine and threonine residues. Phosphorylation of p53 influences its DNA-binding and gene regulation activities. This study examines p53 phosphorylation in HCT-116 (MMR-deficient) and HCT-116+ch3 (MMR-proficient) human colon cancer cells treated with a S(N)2 DNA-alkylating agent, methylmethane sulfonate (MMS). MMS induces phosphorylation of p53 on Ser15 and Ser392 in a dose- and time-dependent manner. MMS-induced p53 phosphorylation is independent of DNA mismatch repair (MMR) activity. Nuclear extracts from MMS-treated HCT-116 cells had higher p21(WAF1/Cip1) (p21) promoter DNA-binding activity in vitro opposed to untreated cells. After MMS treatment, the activation of the cloned p21 promoter in a transient transfection assay and endogenous p21 mRNA levels in HCT-116(p53(+/+)) versus HCT-116(p53(-/-)) cells increased, which correlates with an increased levels of phospho-p53(Ser15) and phospho-p53(Ser392). These results suggest that S(N)2 DNA-alkylating agent-induced phosphorylation of p53 on Ser15 and Ser392 increases its DNA-binding properties to cause an increased expression of p21 that may play a role in cell cycle arrest and/or apoptosis of HCT-116 cells. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 30
页数:14
相关论文
共 50 条
  • [21] STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activation
    Santarelli, Roberta
    Carillo, Valentina
    Romeo, Maria Anele
    Gaeta, Aurelia
    Nazzari, Cristina
    Gonnella, Roberta
    Granato, Marisa
    D'Orazi, Gabriella
    Faggioni, Alberto
    Cirone, Mara
    VIROLOGY, 2019, 528 : 137 - 143
  • [22] Tumorigenicity of Human Induced Pluripotent Stem Cells Depends on the Balance of Gene Expression Between p21 and p53
    Moriguchi, Hisashi
    Chung, Raymond T.
    Sato, Chifumi
    HEPATOLOGY, 2010, 51 (03) : 1088 - 1089
  • [23] Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression
    MacKenzie Ross, Alastair D.
    Cook, Martin G.
    Chong, Heung
    Hossain, Mehnaz
    Pandha, Hardev S.
    Bennett, Dorothy C.
    PIGMENT CELL & MELANOMA RESEARCH, 2013, 26 (02) : 226 - 235
  • [24] Expression of p21 and p27 in hepatoma cell lines with different p53 gene profile
    Bhardwaj, B
    Bhardwaj, G
    Lau, JYN
    JOURNAL OF HEPATOLOGY, 1999, 31 (02) : 386 - 386
  • [25] Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis
    Attardi, LD
    Lowe, SW
    Brugarolas, J
    Jacks, T
    EMBO JOURNAL, 1996, 15 (14): : 3693 - 3701
  • [26] p53 modulates radiation sensitivity independent of p21 transcriptional activation
    Mazzatti, DJ
    Lee, YD
    Helt, CE
    O'Reilly, MA
    Keng, PC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (01): : 43 - 50
  • [27] DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
    Blattner, C
    Tobiasch, E
    Litfen, M
    Rahmsdorf, HJ
    Herrlich, P
    ONCOGENE, 1999, 18 (09) : 1723 - 1732
  • [28] DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
    Christine Blattner
    Edda Tobiasch
    Margarethe Litfen
    Hans J Rahmsdorf
    Peter Herrlich
    Oncogene, 1999, 18 : 1723 - 1732
  • [29] p53, p21, and p73 Gene Polymorphisms in Gastric Carcinoma
    Shirai, Osamu
    Ohmiya, Naoki
    Taguchi, Ayumu
    Nakamura, Masanao
    Kawashima, Hiroki
    Miyahara, Ryoji
    Itoh, Akihiro
    Hirooka, Yoshiki
    Watanabe, Osamu
    Ando, Takafumi
    Goto, Yasuyuki
    Hamajima, Nobuyuki
    Goto, Hidemi
    HEPATO-GASTROENTEROLOGY, 2010, 57 (104) : 1595 - 1601
  • [30] Significance of p53, Bcl-2 and p21(WAF-1) (p21) expression in lung carcinoma.
    Madan, SK
    Lee, PJ
    Valdivieso, M
    Sarkar, FH
    LABORATORY INVESTIGATION, 1996, 74 (01) : 935 - 935